Regulations.gov document
Appendix 1- Pioneer Product Label - Deramaxx™ (deracoxib) Chewable Tablets, Elanco US…
Supporting & Related Material · FDA-2018-P-1740 · posted May 3, 2018
Key facts
| Document ID | FDA-2018-P-1740-0003 |
|---|---|
| Title | Appendix 1- Pioneer Product Label - Deramaxx™ (deracoxib) Chewable Tablets, Elanco US Inc., NADA 141-203 |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2018-P-1740 |
| Posted | May 3, 2018 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: